As of October 14, 2026, DOT marijuana testing is unchanged. DOT safety-sensitive employees can still be tested for marijuana, and a medical marijuana card or CBD use is not a valid medical explanation for a DOT marijuana positive. The April 2026 order changed the federal schedule for a limited group of medical marijuana products, but it did not change the DOT testing process.
Short answer: does marijuana rescheduling change a DOT drug test?
No. As of October 14, 2026, DOT says marijuana remains unacceptable for employees in DOT safety-sensitive jobs, including pilots, truck and school-bus drivers, train engineers, ship captains, aircraft maintenance personnel, and pipeline emergency responders. DOT’s December 19, 2025 marijuana testing notice says its testing process and regulations do not change until broader rescheduling is complete.
That means a DOT test is not decided by whether a state permits marijuana, whether you have a medical card, or whether a product was sold as CBD. If you work in a safety-sensitive role, treat the employer’s DOT testing notice and policy as the document that matters most.
What changed in April 2026?
On April 28, 2026, a Justice Department and DEA final rule moved two limited categories into Schedule III: FDA-approved drug products containing marijuana and marijuana products regulated under a qualifying state medical marijuana license. DOJ said the order placed these products in Schedule III immediately, on April 23, 2026, and the rule was published in the Federal Register on April 28, 2026. The April 2026 Federal Register rule says this change applies only to those categories.
As of October 14, 2026, other marijuana remains in Schedule I under that rule. This includes unlicensed marijuana crops, bulk marijuana, and marijuana or marijuana extract not yet included in an FDA-approved drug product or covered by a state medical marijuana license. Hemp’s status was not changed by this rule.
The April action was separate from the broader marijuana-rescheduling proceeding. DEA withdrew the earlier 2024 hearing notice and terminated those proceedings on April 28, 2026, then set a new administrative hearing beginning June 29, 2026. The sources reviewed here do not show the outcome of that hearing. As of October 14, 2026, that broader process remains separate from the limited Schedule III order; it is not a blanket federal legalization of marijuana.
Why DOT testing has not changed
DOT’s position is direct: until the rescheduling process is complete, DOT-regulated safety-sensitive employees remain subject to marijuana testing under 49 CFR Part 40. A Schedule III label for a limited group of medical products does not remove marijuana from the DOT testing program.
A medical card also does not change how the Medical Review Officer, or MRO, verifies a DOT result. Under 49 CFR 40.151, an MRO must not verify a result as negative because a physician recommended a Schedule I drug under a state medical-marijuana law. The rule also says an MRO cannot accept claimed hemp or other non-prescription marijuana-related product use as a reason to verify a marijuana result as negative.
CBD is not the substance DOT tests for; DOT tests for marijuana. But DOT’s CBD notice says CBD use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive. The notice also warns that CBD labels may not accurately reflect THC content. For a wider explanation of product-label questions, see CBD and drug tests.
What happens after a DOT positive?
The MRO process gives you a chance to discuss the result. Under 49 CFR 40.135, the MRO must tell you the laboratory’s result, identify the drug involved, explain the verification interview, and base the decision on the information you provide during that interview.
If an MRO verifies a positive, adulterated, substituted, or refusal result, you can request testing of the split specimen within 72 hours of notification. Under 49 CFR 40.171, a timely request directs the original laboratory to send the split specimen to a second HHS-certified laboratory. This is different from taking a new test on your own: Part 40 says an MRO must disregard tests that were not collected or tested under Part 40.
For questions about what a result label means, including dilute, invalid, or substituted findings, see THC result meanings. Do not try to alter, dilute, substitute, or mask a specimen. DOT laboratories conduct specimen-validity testing as part of the Part 40 process.
If you drive or work in a safety-sensitive job
Keep the next steps simple:
- Read the DOT notice from your employer or testing program and confirm which agency rules apply to your job.
- If contacted by an MRO, respond promptly and prepare to discuss the result through the verification interview.
- If you want split-specimen testing after a verified result, make that request within the 72-hour window.
- For a urine collection question, including the required amount, ask the collection site for its DOT collection instructions rather than relying on a general online answer.
- If state employment protections may matter, check the law for your own state and position. DOT-required testing can be an exception even where local rules limit some workplace testing.
For example, New York City’s pre-employment marijuana-testing rules include an exception for testing required by DOT under Part 40. Illinois law allows employers to keep reasonable zero-tolerance or drug-free workplace policies. Those rules are state and local examples, not nationwide protections for DOT employees.
Before you rely on a medical card or CBD product
| Question | What matters for a DOT employee |
|---|---|
| Does a medical card explain a positive? | No. Part 40 does not allow an MRO to verify a marijuana positive as negative based on a state medical-marijuana recommendation. |
| Does CBD explain a positive? | No. DOT says CBD use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive. |
| Did April 2026 legalize marijuana federally? | No. The order was limited to FDA-approved marijuana products and marijuana under qualifying state medical licenses. |
| Can a new personal test replace the DOT result? | No. An MRO must disregard tests outside the Part 40 collection and testing process. |
| What can be requested after verification? | A test of the split specimen may be requested within 72 hours of notification. |
This is general information, not legal advice. Deadlines can be short, so speak with HR, a union representative, or an employment lawyer quickly if a DOT result or employment decision affects you.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
